Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1,277.50
-6.10
(-0.48%)
At close: February 28 at 3:30:01 PM GMT+5:30
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 19.64M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Pillai (Sajitha) Promoter | Sale at price 17.67 per share. | Direct | 88,367 | Feb 6, 2025 |
Pillai (Sajitha) Promoter | Sale at price 17.69 per share. | Direct | 44,235 | Feb 5, 2025 |
Pillai (Sajitha) Promoter | Sale at price 17.52 per share. | Direct | 87,596 | Feb 4, 2025 |
Pillai (Hemalatha) Promoter | Sale at price 16.71 per share. | Direct | 300,772 | Feb 3, 2025 |
Sharma (Neeraj) Director | Sale at price 17.10 per share. | Direct | 342,030 | Feb 3, 2025 |
Pillai (Hemalatha) Promoter | Sale at price 18.25 per share. | Direct | 219,046 | Jan 31, 2025 |
Pillai (Padmakumar Karunakaran) Promoter | Sale at price 18.01 per share. | Direct | 900,625 | Jan 31, 2025 |
Pillai (Vineetha Mohankumar) Promoter | Sale at price 18.09 per share. | Direct | 859,241 | Jan 31, 2025 |
Pronomz Ventures LLP Promoter | Sale at price 17.85 per share. | Direct | 10,400,266 | Jan 31, 2025 |
Tenshi Pharmaceuticals Pvt. Ltd. Promoter | Sale at price 17.70 per share. | Direct | 58,429,149 | Jan 31, 2025 |
Related Tickers
CONCORDBIO.NS Concord Biotech Limited
1,501.00
-5.56%
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
RLYB Rallybio Corporation
0.7223
-2.39%
IMTX Immatics N.V.
4.3800
0.00%
ENSC Ensysce Biosciences, Inc.
5.39
+2.67%
PTGX Protagonist Therapeutics, Inc.
37.59
+3.44%
SION Sionna Therapeutics, Inc.
13.77
-6.71%
NKTR Nektar Therapeutics
0.8500
+6.76%
RIGL Rigel Pharmaceuticals, Inc.
23.06
+5.88%
ALLO Allogene Therapeutics, Inc.
1.9500
0.00%